214 related articles for article (PubMed ID: 10983616)
1. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
Hampel F; Lisberg E; Guérin JC
J Asthma; 2000 Aug; 37(5):389-98. PubMed ID: 10983616
[TBL] [Abstract][Full Text] [Related]
2. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
4. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
[TBL] [Abstract][Full Text] [Related]
5. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ; Stampone P; O'Connor BJ
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
8. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
Nayak A; Lanier R; Weinstein S; Stampone P; Welch M
Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
[TBL] [Abstract][Full Text] [Related]
10. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
[TBL] [Abstract][Full Text] [Related]
11. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M; Wettenger R; Gans SJ
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[TBL] [Abstract][Full Text] [Related]
13. Inhaled beclomethasone versus placebo for chronic asthma.
Adams NP; Bestall JB; Malouf R; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD002738. PubMed ID: 15674896
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
Matthys H; Nowak D; Hader S; Kunkel G
Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A; Hall I; Spelman R
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[TBL] [Abstract][Full Text] [Related]
16. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
Boulet LP
Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
[TBL] [Abstract][Full Text] [Related]
17. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
Ederle K;
Eur Rev Med Pharmacol Sci; 2003; 7(2):45-55. PubMed ID: 12911119
[TBL] [Abstract][Full Text] [Related]
18. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
Juniper EF; Price DB; Stampone PA; Creemers JP; Mol SJ; Fireman P
Chest; 2002 Jun; 121(6):1824-32. PubMed ID: 12065345
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
Boulet LP; Cartier A; Ernst P; Larivée P; Laviolette M
Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
[TBL] [Abstract][Full Text] [Related]
20. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
Ayres JG; Simmons JL; Stampone P
Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
